Search

John Mabry

Examiner (ID: 2541)

Most Active Art Unit
1625
Art Unit(s)
1609, 1625, CQIC
Total Applications
541
Issued Applications
359
Pending Applications
3
Abandoned Applications
183

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4887706 [patent_doc_number] => 20080262038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-23 [patent_title] => 'Diarylmethylidene Piperidine Derivatives, Preparations Thereof and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/596853 [patent_app_country] => US [patent_app_date] => 2005-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13549 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20080262038.pdf [firstpage_image] =>[orig_patent_app_number] => 10596853 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/596853
Diarylmethylidene Piperidine Derivatives, Preparations Thereof and Uses Thereof Jan 4, 2005 Abandoned
Array ( [id] => 7225292 [patent_doc_number] => 20050261334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Bis-pyridino containing compounds for the use in the treatment of CNS pathologies' [patent_app_type] => utility [patent_app_number] => 11/027675 [patent_app_country] => US [patent_app_date] => 2005-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16037 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261334.pdf [firstpage_image] =>[orig_patent_app_number] => 11027675 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/027675
Bis-pyridino containing compounds for the use in the treatment of CNS pathologies Jan 2, 2005 Abandoned
Array ( [id] => 4985848 [patent_doc_number] => 20070152186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Reactive oxygen detecting and/or absorbing compound, method for preparing said compound and a device comprising it' [patent_app_type] => utility [patent_app_number] => 10/596557 [patent_app_country] => US [patent_app_date] => 2004-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3458 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20070152186.pdf [firstpage_image] =>[orig_patent_app_number] => 10596557 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/596557
Reactive oxygen detecting and/or absorbing compound, method for preparing said compound and a device comprising it Dec 14, 2004 Abandoned
Array ( [id] => 5178120 [patent_doc_number] => 20070179180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Novel m3 muscarinic acetylcholine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/581229 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7709 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179180.pdf [firstpage_image] =>[orig_patent_app_number] => 10581229 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/581229
Novel m3 muscarinic acetylcholine receptor antagonists Dec 2, 2004 Abandoned
Array ( [id] => 5178124 [patent_doc_number] => 20070179184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Novel m3 muscarinic acetylcholine receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/581230 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5642 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0179/20070179184.pdf [firstpage_image] =>[orig_patent_app_number] => 10581230 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/581230
Novel m3 muscarinic acetylcholine receptor antagonists Dec 2, 2004 Abandoned
Array ( [id] => 6983909 [patent_doc_number] => 20050153979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Novel piperidine-substituted indoles-or heteroderivatives thereof' [patent_app_type] => utility [patent_app_number] => 10/990059 [patent_app_country] => US [patent_app_date] => 2004-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11058 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153979.pdf [firstpage_image] =>[orig_patent_app_number] => 10990059 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/990059
Piperidine-substituted indoles-or heteroderivatives thereof Nov 15, 2004 Issued
Array ( [id] => 4939480 [patent_doc_number] => 20080076799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-27 [patent_title] => 'Piperidinic Derivatives, Pharmaceutic Compositions Containing the Same and Preparation Processes' [patent_app_type] => utility [patent_app_number] => 11/576864 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9595 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20080076799.pdf [firstpage_image] =>[orig_patent_app_number] => 11576864 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/576864
Piperidinic derivatives, pharmaceutic compositions containing the same and preparation processes Oct 14, 2004 Issued
Array ( [id] => 5136537 [patent_doc_number] => 20070078166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone' [patent_app_type] => utility [patent_app_number] => 10/574712 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11634 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078166.pdf [firstpage_image] =>[orig_patent_app_number] => 10574712 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/574712
Crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone Oct 11, 2004 Issued
Array ( [id] => 4966000 [patent_doc_number] => 20080108820 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-08 [patent_title] => 'Hemiasterlin Derivatives and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/572871 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47994 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20080108820.pdf [firstpage_image] =>[orig_patent_app_number] => 10572871 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/572871
Hemiasterlin Derivatives and Uses Thereof Sep 21, 2004 Abandoned
Array ( [id] => 74742 [patent_doc_number] => 07750161 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-06 [patent_title] => 'Pyridine derivatives' [patent_app_type] => utility [patent_app_number] => 10/573516 [patent_app_country] => US [patent_app_date] => 2004-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23494 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/750/07750161.pdf [firstpage_image] =>[orig_patent_app_number] => 10573516 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/573516
Pyridine derivatives Sep 20, 2004 Issued
Array ( [id] => 300031 [patent_doc_number] => 07538233 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-05-26 [patent_title] => 'Coumarins as iNOS inhibitors' [patent_app_type] => utility [patent_app_number] => 10/925292 [patent_app_country] => US [patent_app_date] => 2004-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20038 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/538/07538233.pdf [firstpage_image] =>[orig_patent_app_number] => 10925292 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/925292
Coumarins as iNOS inhibitors Aug 23, 2004 Issued
Array ( [id] => 5732870 [patent_doc_number] => 20060257987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-16 [patent_title] => 'Ppar modulators' [patent_app_type] => utility [patent_app_number] => 10/566291 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 119010 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20060257987.pdf [firstpage_image] =>[orig_patent_app_number] => 10566291 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/566291
Ppar modulators Aug 16, 2004 Abandoned
10/914460 Use of fused imidazoles, aminopyrimidines, isonicotinamides, aminomethyl phenoxypiperidines and aryloxypiperidines to promote and detect endogenous neurogenesis Aug 8, 2004 Abandoned
Array ( [id] => 4772856 [patent_doc_number] => 20080058515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-06 [patent_title] => 'Chemical Compounds' [patent_app_type] => utility [patent_app_number] => 10/566040 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17551 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20080058515.pdf [firstpage_image] =>[orig_patent_app_number] => 10566040 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/566040
Chemical Compounds Jul 22, 2004 Abandoned
Array ( [id] => 5035608 [patent_doc_number] => 20070100147 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Process for preparing raloxifene hydrochloride' [patent_app_type] => utility [patent_app_number] => 10/562762 [patent_app_country] => US [patent_app_date] => 2004-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2615 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20070100147.pdf [firstpage_image] =>[orig_patent_app_number] => 10562762 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/562762
Process for preparing raloxifene hydrochloride Jun 27, 2004 Abandoned
Array ( [id] => 7011423 [patent_doc_number] => 20050065139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Glycosidase inhibitors and methods of synthesizing same' [patent_app_type] => utility [patent_app_number] => 10/877490 [patent_app_country] => US [patent_app_date] => 2004-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 35227 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065139.pdf [firstpage_image] =>[orig_patent_app_number] => 10877490 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/877490
Glycosidase inhibitors and methods of synthesizing same Jun 24, 2004 Abandoned
Array ( [id] => 5890112 [patent_doc_number] => 20060276507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Hydroxamate sulfonamides as cd23 shedding inhibitors' [patent_app_type] => utility [patent_app_number] => 10/560327 [patent_app_country] => US [patent_app_date] => 2004-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15539 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20060276507.pdf [firstpage_image] =>[orig_patent_app_number] => 10560327 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/560327
Hydroxamate sulfonamides as cd23 shedding inhibitors Jun 17, 2004 Abandoned
Array ( [id] => 7978065 [patent_doc_number] => 08071780 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-12-06 [patent_title] => '2-Hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide' [patent_app_type] => utility [patent_app_number] => 10/560385 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6527 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/071/08071780.pdf [firstpage_image] =>[orig_patent_app_number] => 10560385 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/560385
2-Hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide Jun 8, 2004 Issued
Array ( [id] => 5016709 [patent_doc_number] => 20070259918 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => '2-Hydroxymethyl-3,4,5-Trihydroxy-1-(4-Pentyloxybenzyl) Piperidine as Glucosylceramide Synthase (Gcs) Inhibitor' [patent_app_type] => utility [patent_app_number] => 10/560383 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5998 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259918.pdf [firstpage_image] =>[orig_patent_app_number] => 10560383 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/560383
2-hydroxymethy1-3,4,5-trihydroxy-1-(4-pentyloxybenzyl) piperidine as glucosylceramide synthase (Gcs) inhibitor Jun 8, 2004 Issued
Array ( [id] => 5107730 [patent_doc_number] => 20070066608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'Novel indole derivatives with an improved antipsychotic activity' [patent_app_type] => utility [patent_app_number] => 10/556931 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10521 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066608.pdf [firstpage_image] =>[orig_patent_app_number] => 10556931 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/556931
Novel indole derivatives with an improved antipsychotic activity May 25, 2004 Abandoned
Menu